Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Physostigmine MeSH Descriptor Data 2025


MeSH Heading
Physostigmine
Tree Number(s)
D02.241.081.251.583.682
D03.132.436.545
D03.633.100.473.402.545
D03.633.100.496.500.500.545
Unique ID
D010830
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D010830
Scope Note
A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.
Entry Term(s)
Eserine
Pharm Action
Cholinesterase Inhibitors
Miotics
Registry Numbers
9U1VM840SP
0
Related Numbers
57-47-6
CAS Type 1 Name
Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-
NLM Classification #
QV 124
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2020/05/27
Physostigmine Preferred
Eserine Narrower
page delivered in 0.145s